Evidence map›Paper›PMID 35215786›Full record

ReviewViruses2022

Anant Patil, Mohamad Goldust, Uwe Wollina

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 259 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
259citing papers in PubMed, 6 pooled it
58.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06798662 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain: a Prospective, Randomized, Controlled, Triple-blind Trial

TypeinterventionalSponsorXiaguang DuanRan2025 to 2025Enrolled120ConditionsHerpes Zoster (HZ)ArmsUltrasound-Guided Pulsed Radiofrequency (PRF), Intercostal nerve block (2% ropivacaine or 133 mg of liposomal bupivacaine), Paravertebral (PVB) Block (2% ropivacaine or 133 mg of liposomal bupivacaine), Rhomboid Intercostal and Subserratus Plane (RISS) Block (2% ropivacaine or 133 mg of liposomal bupivacaine), Drug (famciclovir and gabapentin)
NCT06985589 phase4completednot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of Fire Needle Therapy Combined With Cortex Phellodendri Compound Fluid Wet Compress for Acute Herpes Zoster: a Randomized Controlled Trial.

TypeinterventionalSponsorSecond Affiliated Hospital of Xi'an Jiaotong UniversityRan2024 to 2024Enrolled32ConditionsAcute Herpes ZosterArmsFire needle, Cortex Phellodendri compound fluid wet compress, basic treatment
3 · Its place in the literature

Who cites it

259 citing papers in PubMed, 6 syntheses or guidelines pooled it, 402 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Varicella zoster virus infection.Nature reviews. Disease primers · 2026
    Review
  14. Atopic dermatitis is associated with herpes zoster in adults - A matched cohort study using electronic health records data in England.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Dermatologic Toxicities Induced by JAK Inhibitors.American journal of clinical dermatology · 2026
    Review

199 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Anant PatilDepartment of Pharmacology, Dr. DY Patil Medical College, Navi Mumbai 400706, India.ORCID 0000-0002-9455-4025
Mohamad GoldustDepartment of Dermatology, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.ORCID 0000-0002-8646-1179
Uwe WollinaDepartment of Dermatology and Allergology, Städtisches Klinikum Dresden, 01067 Dresden, Germany.ORCID 0000-0001-5933-2913
Dr. D. Y. Patil Medical College, Hospital and Research Centre · INJohannes Gutenberg University Mainz · DEStädtisches Klinikum Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Disease ManagementHerpesvirus 3, HumanHerpesvirus VaccinesHerpes ZosterHumansImmunocompromised HostIncidenceLatent InfectionMorbidityNeuralgia, PostherpeticRisk FactorsVaccinationVaccines, SyntheticHerpesvirus VaccinesVaccines, SyntheticcomplicationsepidemiologyHerpes zosterpreventiontreatmentVaricella-zoster virus

Identifiers

PMID35215786
PMCPMC8876683
OpenAlexW4205658817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.